China’s Ministry of Commerce--Time to Strengthen Biopharma Complex for Global Competition, Incoming Trump Admin Should Take Notice

0 comment

Staff at TrialSite | Quality Journalism

Nov. 25, 2024, 2:00 p.m.

On November 21, 2024, China’s Ministry of Commerce issued a declaration titled "Several Measures to Support Suzhou Industrial Park to Deepen the Comprehensive Experiment of Open Innovation." This matters for the biopharmaceutical complex worldwide. This industry park on the eastern Chinese coast is a significant hub for biotechnology in China. Over the years, it has developed into one of the country's leading centers for biopharmaceutical and life sciences industries, attracting domestic and international companies, research institutions, and talent.

The Suzhou Industrial Park (SIP) is a development region in Suzhou, Jiangsu, China, about 110 km to the west of Shanghai.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month
which is less than a Starbucks coffee!

Peter Gabriel, MD

"Publishing on TrialSite helped me secure a $20m research grant for my work."

Jona Savinda

"TrialSiteNews is my daily read for what is happening in the industry."